Aging
Aging
Improving Older Age
Our research fosters policies to enhance the physical and financial wellbeing of older people as the aging population grows.
Featured Article
Dementia Will Cost the U.S. $818 Billion in 2026, USC-Led Study Finds
People with dementia and their families bear staggering, often-hidden costs. Tracking changes in cost over time can help inform decisions about treatment and resource allocation.
Experts: Julie Zissimopoulos, Dana Goldman, Bryan Tysinger, Johanna Thunell
Related Subtopics
Increased longevity brings obvious benefits as well as considerable challenges — from Alzheimer’s and other age-related diseases to increased injuries, disabilities and poverty risks. Policymakers around the world rely on Schaeffer research and modeling tools for finding ways to help keep people as healthy as possible throughout their lives.
Top Aging Stories View All
Issue Brief
Fixing the Funnel: Stakeholder Insights on Alzheimer’s Disease Trial Recruitment
Featured Experts: Phyllis Barkman Ferrell, Maria-Alice Manetas, Mireille Jacobson, Desi Peneva
In The News View All
MarketWatch
Dementia’s growing costs are an economic crisis for families and government, Zissimopoulos warns
Featured Experts: Julie Zissimopoulos
The New York Times
Joyce discusses researchers’ efforts to study if statins can prevent dementia
Featured Experts: Geoffrey Joyce
Bloomberg
Bloomberg cites Schaeffer Center data on 2025 dementia costs
Featured Experts: Julie Zissimopoulos
Healio
Zissimopoulos discusses how the U.S. Cost of Dementia project will help policymakers identify opportunities to reduce costs
Featured Experts: Julie Zissimopoulos
Marketplace
Heun-Johnson quoted on how excess COVID-19 deaths affected Social Security finances
Featured Experts: Hanke Heun-Johnson
Featured White Paper
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
New technology can detect multiple types of cancer with one blood draw and could lead to improved cancer outcomes. Policymakers should prioritize efforts to determine eligibility criteria to ensure access when these tests are available.
Read the White Paper
Related NIH-Funded Centers
Our NIH-funded centers are advancing knowledge of the health, economic and social impacts of Alzheimer’s disease and related dementias.
Featured Op-Ed
Why Widespread Testing for Alzheimer’s Is Essential
New blood tests can detect Alzheimer’s earlier and more accurately, enabling earlier intervention and more effective use of emerging therapies. Federal policies must ensure these advances reach patients.
Read the Op-Ed
